Scalzone Annachiara, Imparato Giorgia, Urciuolo Francesco, Netti Paolo A
Center for Advanced Biomaterials for Health Care, Istituto Italiano di Tecnologia, Largo Barsanti e Matteucci 53, Naples 80125, Italy.
Department of Chemical, Materials and Industrial Production Engineering (DICMAPI), University of Naples Federico II, P.le Tecchio 80, Naples 80125, Italy.
Biofabrication. 2024 Apr 15;16(3). doi: 10.1088/1758-5090/ad3aa5.
The advent of 3D bioprinting technologies in tissue engineering has unlocked the potential to fabricatetissue models, overcoming the constraints associated with the shape limitations of preformed scaffolds. However, achieving an accurate mimicry of complex tissue microenvironments, encompassing cellular and biochemical components, and orchestrating their supramolecular assembly to form hierarchical structures while maintaining control over tissue formation, is crucial for gaining deeper insights into tissue repair and regeneration. Building upon our expertise in developing competent three-dimensional tissue equivalents (e.g. skin, gut, cervix), we established a two-step bottom-up approach involving the dynamic assembly of microtissue precursors (TPs) to generate macroscopic functional tissue composed of cell-secreted extracellular matrix (ECM). To enhance precision and scalability, we integrated extrusion-based bioprinting technology into our established paradigm to automate, control and guide the coherent assembly ofTPs into predefined shapes. Compared to cell-aggregated bioink, ourTPs represent a functional unit where cells are embedded in their specific ECM.TPs were derived from human dermal fibroblasts dynamically seeded onto gelatin-based microbeads. After 9 days,TPs were suspended (50% v/v) in Pluronic-F127 (30% w/v) (TP:P30), and the obtained formulation was loaded as bioink into the syringe of the Dr.INVIVO-4D6 extrusion based bioprinter.TP:P30 bioink showed shear-thinning behavior and temperature-dependent viscosity (gel at> 30 °C), ensuringTPs homogenous dispersion within the gel and optimal printability. The bioprinting involved extruding several geometries (line, circle, and square) into Pluronic-F127 (40% w/v) (P40) support bath, leveraging its shear-recovery property. P40 effectively held the bioink throughout and after the bioprinting procedure, untilTPs fused into a continuous connective tissue.TPs fusion dynamics was studied over 8 days of culture, while the resulting endogenous construct underwent 28 days culture. Histological, immunofluorescence analysis, and second harmonic generation reconstruction revealed an increase in endogenous collagen and fibronectin production within the bioprinted construct, closely resembling the composition of the native connective tissues.
3D生物打印技术在组织工程中的出现,开启了制造组织模型的潜力,克服了与预制支架形状限制相关的约束。然而,实现对复杂组织微环境的精确模拟,包括细胞和生化成分,并协调它们的超分子组装以形成层次结构,同时保持对组织形成的控制,对于深入了解组织修复和再生至关重要。基于我们在开发有能力的三维组织等效物(如皮肤、肠道、子宫颈)方面的专业知识,我们建立了一种自下而上的两步法,涉及微组织前体(TPs)的动态组装,以生成由细胞分泌的细胞外基质(ECM)组成的宏观功能组织。为了提高精度和可扩展性,我们将基于挤出的生物打印技术集成到我们已建立的模式中,以自动控制和引导TPs连贯组装成预定义的形状。与细胞聚集生物墨水相比,我们的TPs代表一个功能单元,其中细胞嵌入其特定的ECM中。TPs来源于动态接种在明胶基微珠上的人真皮成纤维细胞。9天后,将TPs(50% v/v)悬浮在Pluronic-F127(30% w/v)(TP:P30)中,将所得制剂作为生物墨水加载到Dr.INVIVO-4D6基于挤出的生物打印机的注射器中。TP:P30生物墨水表现出剪切变稀行为和温度依赖性粘度(在>30°C时为凝胶),确保TPs在凝胶中均匀分散并具有最佳可打印性。生物打印包括将几种几何形状(线、圆和正方形)挤出到Pluronic-F127(40% w/v)(P40)支撑浴中,利用其剪切恢复特性。P40在整个生物打印过程中和之后有效地保持生物墨水,直到TPs融合成连续的结缔组织。在8天的培养过程中研究了TPs的融合动力学,而所得的内源性构建体进行了28天的培养。组织学、免疫荧光分析和二次谐波生成重建显示,生物打印构建体内内源性胶原蛋白和纤连蛋白的产生增加,与天然结缔组织的组成非常相似。